RareCyte

RareCyte is a biotech company in Seattle, United States, founded in 2006. It has raised $74.7M across 5 rounds, most recently a $658K Grant in June 2025.

High-Plex Spatial Proteomics at Clinical Research Scale

Employees
51–200
Founded
2006
Business Model
B2B
Total Funding
$74.7M
Last Round
$658K GrantJun 2025
Rounds
5

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 5 funding rounds and 5 investors for this company. The full record is or through the API.

About

RareCyte develops advanced spatial biology and liquid biopsy technologies that deliver the reliable data researchers need to accelerate biomarker development and advance precision biology at clinical scale. The Orion spatial proteomics platform delivers the multiplex depth, throughput, and reproducible data quality researchers need to advance biomarker programs. Designed for CTC monitoring in global clinical trials, the CyteFinder platform accurately and reproducibly phenotypes as few as 1 CTC per tube of blood. RareCyte also accelerates biomarker programs with custom assay development, clinical trial testing, and biomarker research services, and is a proven partner to over 100 biopharma and leading academic institutions.

Summary

It lists 51–200 employees. It has raised $74.7M in total across 5 rounds, most recently a $658K Grant round in Jun 2025. Investors include Arboretum Ventures, F-Prime Capital and HealthQuest Capital.

Tech & App Stack

8 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Data from Indexed.vcUpdated
GrantSBIR Phase II (NIH)Jun 2025
$658K

Sign up to see all 5 events

Funding: Series A through Grant. Amounts, valuations, and investors where available.

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

RareCyte on Indexed.vc
<a href="https://indexed.vc/companies/rarecyte"><img src="https://indexed.vc/api/badge/company/rarecyte" alt="RareCyte on Indexed.vc" width="260" height="76" /></a>